Back

GLP-1 receptor agonist use and clinical outcomes after atrial fibrillation ablation: a 110-center real-world analysis

29 August 2026 (09:09 - 09:27)
Organised by: Logo
Congress Presentation Part of: Ablation for atrial fibrillation: new insights, better outcomes Rhythm Control, Catheter Ablation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Nont Paisarntanawat

(Thailand)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on ablation for atrial fibrillation: new insights, better outcomes
Professor J. Kalman (Melbourne, AU)
Slides Video
Presentation thumbnail
Long-term clinical outcomes of catheter ablation versus pacemaker implantation in patients with atrial fibrillation and sick sinus syndrome: a multicenter real-world cohort study
Mx X. Yang (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
The effect of pulsed field versus radiofrequency pulmonary vein isolation on the cardiac autonomic nervous system in the BEAT PAROX-AF randomized trial
Professor D. Wichterle (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Risk factors of atrial arrhythmia recurrence and impact on the benefit of oral anticoagulation discontinuation: insights from the ALONE-AF trial
Doctor K. Dongseon (Anyang-Si- Gyeonggi-Do, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Ablation for atrial fibrillation: new insights, better outcomes
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 09:09 CET
You may be interested in
thumbnail
Congress Presentation
Effect of glucagon-like peptide-1 agonists on ventricular tachycardia ablation outcomes
1 September 2025
thumbnail
Congress Session
Smaller trials, trial updates, and other studies: atrial fibrillation detection, prevention and treatment
31 August 2024
thumbnail
Congress Presentation
Impact of GLP-1 receptor agonists on risk of stroke in patients with atrial fibrillation: a Danish nationwide cohort study
29 August 2026
thumbnail
Congress Presentation
Peri-ablation semaglutide exposure and atrial fibrillation recurrence: a meta-analysis of time-to-event outcomes
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources